What PatientWing does

PatientWing (legally VitalTrax, LLC) is a Philadelphia-based, private clinical trial enrollment platform operating in a B2B model that serves pharmaceutical sponsors, contract research organizations (CROs), and clinical research sites. The company specializes in direct-to-patient enrollment, with particular emphasis on rare diseases and autoimmune conditions including myositis, scleroderma, Sjögren's, rheumatoid arthritis, lupus nephritis, ANCA-associated vasculitis, autoimmune hepatitis, gout, and membranous nephropathy. Its go-to-market is enterprise field sales, with pricing negotiated directly with sponsors and CROs on multi-year contracts under a managed-services structure; specific pricing is not publicly disclosed.

The core product is a web-based platform (patientwing.com and app.patientwing.com) that combines condition-specific patient communities, an educational resource hub, branded study campaign landing pages hosted on subdomains, and an authenticated patient portal. For sponsors, PatientWing provides eligibility questionnaires, phone consultations, medical record collection, and research site referrals. The platform is HIPAA-compliant as a Business Associate and includes a physician referral portal enabling healthcare providers to refer eligible patients into studies. Active branded campaigns visible on the company's homepage span at least a dozen programs across cardiovascular, oncology, nephrology, neurology, and rheumatology indications, with one publicly named enterprise partner — Artiva Biotherapeutics — engaged across four AlloNK autoimmune studies.

The company is co-founded by Zikria Syed (CEO) and Todd Kueny (CTO), operates with 11–50 employees, and reports no disclosed funding rounds, revenue, ownership, or investor backing in the available data. PatientWing does not host or run clinical trials itself; it functions as an enrollment intermediary connecting patients with research sites conducting trials. Its competitive positioning rests on domain specialization in rare/autoimmune indications, condition-specific community engagement, and a templated campaign-page infrastructure for individual studies.

Name

PatientWing

Legal name

VitalTrax, LLC

Website

https://patientwing.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

PatientWing (d/b/a VitalTrax, LLC) is a Philadelphia-based direct-to-patient clinical trial enrollment platform serving pharmaceutical sponsors, CROs, and research sites, with specialized focus on rare disease and autoimmune condition studies in the United States.

Ownership category

akta.pro rank

Headquarters

HQ city

Philadelphia

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Clinical Trial Enrollment Services: PatientWing provides enrollment services to pharmaceutical sponsors, CROs, and clinical research sites on a contractual basis. The company helps sponsors accelerate their study timelines by connecting them with eligible patients. Specific pricing and contract terms are negotiated directly with sponsors and are not publicly disclosed.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

PatientWing provides a direct-to-patient clinical trial enrollment platform that helps pharmaceutical sponsors, CROs, and research sites accelerate study enrollment by connecting eligible patients with active trials. The service combines a HIPAA-compliant web platform, condition-specific landing pages, online eligibility questionnaires, phone consultations, and medical record collection workflows, with particular emphasis on rare disease and autoimmune indications.

Product overview

PatientWing is a direct-to-patient enrollment platform connecting patients with clinical trials to help sponsors accelerate enrollment timelines. The core PatientWing Platform serves both sponsors/CROs (providing enrollment solutions) and patients (via the Clinical Research Education Hub and patient communities). The platform operates branded study campaign pages for individual clinical studies, including the Artiva AlloNK sub-platform covering NK cell therapy studies for four autoimmune conditions, and the Frontier Study site for refractory rheumatoid arthritis. Patients access the platform through the authenticated PatientWing App portal, while sponsors and research sites use the platform to match with eligible participants.

Differentiator

Problem solved

Functional benefit

Products and services

• PatientWing Direct-to-Patient Enrollment Platform A direct-to-patient enrollment platform that connects patients seeking clinical studies with pharmaceutical sponsors, CROs, and research sites, accelerating enrollment timelines through direct outreach, eligibility questionnaires, phone consultations, medical record collection, and research site referrals. Designed for sponsors, CROs, and research sites running rare disease and autoimmune clinical trials.
• PatientWing App (Authenticated Login Portal) An authenticated web portal for patients and study participants to manage their profiles, access study information, and track enrollment status within the PatientWing platform.

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Artiva Biotherapeutics, Inc.coreStrategic or Co-development PartnerArtiva Biotherapeutics partners with PatientWing to help identify potential individuals who may be interested in Artiva's AlloNK clinical studies. PatientWing provides enrollment support for Artiva's studies targeting autoimmune diseases including myositis, scleroderma, Sjögren's, and refractory rheumatoid arthritis. PatientWing assists with eligibility screening, medical record collection, and research site referrals for these studies.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Emerging players

• Massive Bio: Massive Bio uses AI-driven matching to connect cancer patients with oncology clinical trials. Compares to PatientWing on patient recruitment-as-a-service for sponsors, with a narrower oncology focus.

Direct peers

• Elligo Health Research: Elligo operates a clinical research site network and patient enrollment infrastructure that brings trials directly to community physicians. Comparable to PatientWing's emphasis on direct-to-patient and physician-referred enrollment for hard-to-recruit studies.
• Antidote Technologies: Antidote operates a clinical trial patient recruitment and matching platform that connects patients with trials across multiple therapeutic areas. Directly comparable to PatientWing's direct-to-patient enrollment model, with overlap on eligibility questionnaires and sponsor-facing matchmaking services.
• Curebase: Curebase provides a decentralized clinical trial software platform with direct-to-patient enrollment, telehealth-based study visits, and sponsor-facing recruitment tools. Comparable to PatientWing on direct-to-patient enrollment workflows and B2B sales to pharma sponsors.
• Medable: Medable provides a decentralized and hybrid clinical trial platform with eCOA, eConsent, telehealth, and patient-facing apps used by pharma sponsors and CROs. Overlaps with PatientWing's web-based platform approach to direct-to-patient trial participation.
• SubjectWell: SubjectWell is a patient recruitment company for clinical trials that uses consumer-grade marketing to identify and refer prospective participants. Comparable to PatientWing's focus on accelerating enrollment timelines for sponsors through direct patient outreach.
• Reify Health: Reify Health offers StudyTeam and other trial enablement software that helps sites and sponsors accelerate clinical trial enrollment. Comparable to PatientWing on the sponsor-facing trial enablement and patient recruitment workflow.

Broad incumbents

• IQVIA: IQVIA is a global CRO and healthcare data company with substantial patient recruitment, site management, and real-world evidence services. Comparable to PatientWing as a competing patient-recruitment provider within a much broader clinical research portfolio.
• WCG (WIRB-Copernicus Group): WCG provides clinical trial solutions including IRB services, site optimization, and patient recruitment enablement for sponsors. Comparable to PatientWing at the recruitment enablement layer, with a much wider portfolio spanning the trial lifecycle.
• PPD (Thermo Fisher Scientific): PPD is a global CRO offering full-service clinical development including patient recruitment and site optimization. Comparable to PatientWing on the recruitment services layer, with significantly broader scale and service breadth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/patientwing
• Facebookfacebook.com/patientwing
• LinkedInlinkedin.com/company/patientwing
• Instagraminstagram.com/patientwing_

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PatientWing